TBX5 loss-of-function mutation contributes to atrial fibrillation and atypical Holt-Oram syndrome

Guo,Dong‑Feng; Li,Ruo‑Gu; Yuan,Fang; Shi,Hong‑Yu; Hou,Xu‑Min; Qu,Xin‑Kai; Xu,Ying‑Jia; Zhang,Min; Liu,Xu; Jiang,Jin‑Qi; Yang,Yi‑Qing; Qiu,Xing‑Biao

doi:10.3892/mmr.2016.5043

TBX5 loss-of-function mutation contributes to atrial fibrillation and atypical Holt-Oram syndrome

Authors:
- Dong‑Feng Guo
- Ruo‑Gu Li
- Fang Yuan
- Hong‑Yu Shi
- Xu‑Min Hou
- Xin‑Kai Qu
- Ying‑Jia Xu
- Min Zhang
- Xu Liu
- Jin‑Qi Jiang
- Yi‑Qing Yang
- Xing‑Biao Qiu
View Affiliations

Affiliations: Department of Emergency Medicine, Shanghai Gongli Hospital, Second Military Medical University, Shanghai 200135, P.R. China, Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, P.R. China, Department of Emergency Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, P.R. China
Published online on: March 24, 2016 https://doi.org/10.3892/mmr.2016.5043
Pages: 4349-4356

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous genome-wide association studies have demonstrated that single nucleotide polymorphisms in T‑box (TBX)5 are associated with increased susceptibility to atrial fibrillation (AF), and a recent study has causally linked a TBX5 mutation to atypical Holt-Oram syndrome and paroxysmal AF. However, the prevalence and spectrum of TBX5 mutations in patients with AF remain to be elucidated. In the present study, a cohort of 190 unrelated patients with idiopathic AF were prospectively recruited, with 400 unrelated healthy individuals recruited as controls. The coding exons and flanking introns of the TBX5 gene were sequenced in the participants. The functional characteristics of the mutant TBX5 were delineated in contrast with its wild‑type counterpart using a dual‑luciferase reporter assay system. As a result, a novel heterozygous TBX5 mutation, p.P132S, was identified in an index patient with AF, with a mutational prevalence of ~0.53%. Genetic analysis of the proband's family showed that the mutation co‑segregated with AF, and was transmitted in an autosomal dominant pattern. The missense mutation was absent in the 800 control chromosomes, and the altered amino acid was completely evolutionarily conserved across species. Functional analyses revealed that the mutant TBX5 had significantly reduced transcriptional activity. Furthermore, the mutation markedly decreased the synergistic activation between TBX5 and NK2 homeobox 5, another transcription factor which has been causatively linked to AF. The present study was the first, to the best of our knowledge, to report on the association between a TBX5 loss‑of‑function mutation and increased susceptibility to AF. These results provide novel insight into the molecular mechanism underpinning AF, and have potential implications in the development of novel prophylactic and therapeutic strategies for AF, the most common form of sustained cardiac arrhythmia.

View Figures

View References

1	January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, et al: 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 130:e199–e267. 2014. View Article : Google Scholar : PubMed/NCBI
2	Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB and Tsang TS: Secular trends in incidence of atrial fibrillation in olmsted county, minnesota, 1980 to 2000 and implications on the projections for future prevalence. Circulation. 114:119–125. 2006. View Article : Google Scholar : PubMed/NCBI
3	Duncan ME, Pitcher A and Goldacre MJ: Atrial fibrillation as a cause of death increased steeply in England between 1995 and 2010. Europace. 16:797–802. 2014. View Article : Google Scholar : PubMed/NCBI
4	Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M and Zimetbaum P: Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 9:348–356. 2006. View Article : Google Scholar : PubMed/NCBI
5	Ball J, Carrington MJ, McMurray JJ and Stewart S: Atrial fibrilation: Profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 167:1807–1824. 2013. View Article : Google Scholar : PubMed/NCBI
6	Mazurek T, Kiliszek M, Kobylecka M, Skubisz-Głuchowska J, Kochman J, Filipiak K, Królicki L and Opolski G: Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation. Am J Cardiol. 113:1505–1508. 2014. View Article : Google Scholar : PubMed/NCBI
7	Liu G, Yan YP, Zheng XX, Xu YL, Lu J, Hui RT and Huang XH: Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation. Am J Cardiol. 114:1523–1529. 2014. View Article : Google Scholar : PubMed/NCBI
8	Hong K and Xiong Q: Genetic basis of atrial fibrillation. Curr Opin Cardiol. 29:220–226. 2014. View Article : Google Scholar : PubMed/NCBI
9	Wang XH, Huang CX, Wang Q, Li RG, Xu YJ, Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation underlies lone atrial fibrillation. Int J Mol Med. 31:43–50. 2013.
10	Shi HF, Yang JF, Wang Q, Li RG, Xu YJ, Qu XK, Fang WY, Liu X and Yang YQ: Prevalence and spectrum of GJA5 mutations associated with lone atrial fibrillation. Mol Med Rep. 7:767–774. 2013.PubMed/NCBI
11	Sun Y, Yang YQ, Gong XQ, Wang XH, Li RG, Tan HW, Liu X, Fang WY and Bai D: Novel germline GJA5/connexin40 mutations associated with lone atrial fibrillation impair gap junctional intercellular communication. Hum Mutat. 34:603–609. 2013.PubMed/NCBI
12	Huang RT, Xue S, Xu YJ, Zhou M and Yang YQ: A novel NKX2.5 loss-of-function mutation responsible for familial atrial fibrillation. Int J Mol Med. 31:1119–1126. 2013.PubMed/NCBI
13	Xie WH, Chang C, Xu YJ, Li RG, Qu XK, Fang WY, Liu X and Yang YQ: Prevalence and spectrum of Nkx2.5 mutations associated with idiopathic atrial fibrillation. Clinics (Sao Paulo). 68:777–784. 2013. View Article : Google Scholar
14	Yu H, Xu JH, Song HM, Zhao L, Xu WJ, Wang J, Li RG, Xu L, Jiang WF, Qiu XB, et al: Mutational spectrum of the NKX2-5 gene in patients with lone atrial fibrillation. Int J Med Sci. 11:554–563. 2014. View Article : Google Scholar : PubMed/NCBI
15	Li RG, Wang Q, Xu YJ, Zhang M, Qu XK, Liu X, Fang WY and Yang YQ: Mutations of the SCN4B-encoded sodium channel β4 subunit in familial atrial fibrillation. Int J Mol Med. 32:144–150. 2013.PubMed/NCBI
16	Beavers DL, Wang W, Ather S, Voigt N, Garbino A, Dixit SS, Landstrom AP, Li N, Wang Q, Olivotto I, et al: Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. J Am Coll Cardiol. 62:2010–2019. 2013. View Article : Google Scholar : PubMed/NCBI
17	Olesen MS, Refsgaard L, Holst AG, Larsen AP, Grubb S, Haunsø S, Svendsen JH, Olesen SP, Schmitt N and Calloe K: A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation. Cardiovasc Res. 98:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
18	Yang YQ, Xu YJ, Li RG, Qu XK, Fang WY and Liu X: Prevalence and spectrum of PITX2c mutations associated with familial atrial fibrillation. Int J Cardiol. 168:2873–2876. 2013. View Article : Google Scholar : PubMed/NCBI
19	Zhou YM, Zheng PX, Yang YQ, Ge ZM and Kang WQ: A novel PITX2c loss-of-function mutation underlies lone atrial fibrillation. Int J Mol Med. 32:827–834. 2013.PubMed/NCBI
20	Wang J, Zhang DF, Sun YM and Yang YQ: A novel PITX2c loss-of-function mutation associated with familial atrial fibrillation. Eur J Med Genet. 57:25–31. 2014. View Article : Google Scholar
21	Qiu XB, Xu YJ, Li RG, Xu L, Liu X, Fang WY, Yang YQ and Qu XK: PITX2C loss-of-function mutations responsible for idiopathic atrial fibrillation. Clinics (Sao Paulo). 69:15–22. 2014. View Article : Google Scholar
22	Wang J, Zhang DF, Sun YM, Li RG, Qiu XB, Qu XK, Liu X, Fang WY and Yang YQ: NKX2-6 mutation predisposes to familial atrial fibrillation. Int J Mol Med. 34:1581–1590. 2014.PubMed/NCBI
23	Macri V, Mahida SN, Zhang ML, Sinner MF, Dolmatova EV, Tucker NR, McLellan M, Shea MA, Milan DJ, Lunetta KL, et al: A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation. Heart Rhythm. 11:1055–1062. 2014. View Article : Google Scholar : PubMed/NCBI
24	Sinner MF, Tucker NR, Lunetta KL, Ozaki K, Smith JG, Trompet S, Bis JC, Lin H, Chung MK, Nielsen JB, et al: Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation. 130:1225–1235. 2014. View Article : Google Scholar : PubMed/NCBI
25	Holm H, Gudbjartsson DF, Arnar DO, Thorleifsson G, Thorgeirsson G, Stefansdottir H, Gudjonsson SA, Jonasdottir A, Mathiesen EB, Njølstad I, et al: Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet. 42:117–122. 2010. View Article : Google Scholar : PubMed/NCBI
26	Zang X, Zhang S, Xia Y, Li S, Fu F, Li X, Wang F, Zhang R, Tian X, Gao L, et al: SNP rs3825214 in TBX5 is associated with lone atrial fibrillation in Chinese Han population. PLoS One. 8:e649662013. View Article : Google Scholar : PubMed/NCBI
27	Greulich F, Rudat C and Kispert A: Mechanisms of T-box gene function in the developing heart. Cardiovasc Res. 91:212–222. 2011. View Article : Google Scholar : PubMed/NCBI
28	Postma AV, van de Meerakker JB, Mathijssen IB, Barnett P, Christoffels VM, Ilgun A, Lam J, Wilde AA, Lekanne Deprez RH and Moorman AF: A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res. 102:1433–1442. 2008. View Article : Google Scholar : PubMed/NCBI
29	World Medical Association: World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. J Postgrad Med. 48:206–208. 2002.PubMed/NCBI
30	Zhang XL, Qiu XB, Yuan F, Wang J, Zhao CM, Li RG, Xu L, Xu YJ, Shi HY, Hou XM, et al: TBX5 loss-of-function mutation contributes to familial dilated cardiomyopathy. Biochem Biophys Res Commun. 459:166–171. 2015. View Article : Google Scholar : PubMed/NCBI
31	Bruneau BG, Logan M, Davis N, Levi T, Tabin CJ, Seidman JG and Seidman CE: Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol. 211:100–108. 1999. View Article : Google Scholar : PubMed/NCBI
32	Moskowitz IP, Pizard A, Patel VV, Bruneau BG, Kim JB, Kupershmidt S, Roden D, Berul CI, Seidman CE and Seidman JG: The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development. 131:4107–4116. 2004. View Article : Google Scholar : PubMed/NCBI
33	Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE and Seidman JG: A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 106:709–721. 2001. View Article : Google Scholar : PubMed/NCBI
34	Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS and Wang TJ: Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA. 301:2571–2577. 2009. View Article : Google Scholar : PubMed/NCBI
35	Soliman EZ, Prineas RJ, Case LD, Zhang ZM and Goff DC Jr: Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 40:1204–1211. 2009. View Article : Google Scholar : PubMed/NCBI
36	Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB Sr, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, et al: Development of a risk score for atrial fibrillation (Framingham Heart Study): A community-based cohort study. Lancet. 373:739–745. 2009. View Article : Google Scholar : PubMed/NCBI
37	Macfarlane PW, Murray H, Sattar N, Stott DJ, Ford I, Buckley B, Jukema JW, Westendorp RG and Shepherd J: The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. Europace. 13:634–639. 2011. View Article : Google Scholar : PubMed/NCBI
38	Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R and Komuro I: Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet. 28:276–280. 2001. View Article : Google Scholar : PubMed/NCBI
39	Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, et al: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
40	Linhares VL, Almeida NA, Menezes DC, Elliott DA, Lai D, Beyer EC, Campos de Carvalho AC and Costa MW: Transcriptional regulation of the murine Connexin40 promoter by cardiac factors Nkx2-5, GATA4 and Tbx5. Cardiovasc Res. 64:402–411. 2004. View Article : Google Scholar : PubMed/NCBI
41	Maitra M, Schluterman MK, Nichols HA, Richardson JA, Lo CW, Srivastava D and Garg V: Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev Biol. 326:368–377. 2009. View Article : Google Scholar :
42	Jiang JQ, Shen FF, Fang WY, Liu X and Yang YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol Med. 28:1025–1032. 2011.PubMed/NCBI
43	Li J, Liu WD, Yang ZL and Yang YQ: Novel GATA6 loss-of-function mutation responsible for familial atrial fibrillation. Int J Mol Med. 30:783–790. 2012.PubMed/NCBI
44	Hodgson-Zingman DM, Karst ML, Zingman LV, Heublein DM, Darbar D, Herron KJ, Ballew JD, de Andrade M, Burnett JC Jr and Olson TM: Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med. 359:158–165. 2008. View Article : Google Scholar : PubMed/NCBI
45	McDermott DA, Hatcher CJ and Basson CT: Atrial fibrillation and other clinical manifestations of altered TBX5 dosage in typical Holt-Oram syndrome. Circ Res. 103:e962008. View Article : Google Scholar : PubMed/NCBI
46	Patel C, Silcock L, McMullan D, Brueton L and Cox H: TBX5 intragenic duplication: A family with an atypical Holt-Oram syndrome phenotype. Eur J Hum Genet. 20:863–869. 2012. View Article : Google Scholar : PubMed/NCBI
47	Kimura M, Kikuchi A, Ichinoi N and Kure S: Novel TBX5 duplication in a Japanese family with Holt-Oram syndrome. Pediatr Cardiol. 36:244–247. 2015. View Article : Google Scholar
48	Al-Qattan MM and Abou Al-Shaar H: Molecular basis of the clinical features of Holt-Oram syndrome resulting from missense and extended protein mutations of the TBX5 gene as well as TBX5 intragenic duplications. Gene. 560:129–136. 2015. View Article : Google Scholar : PubMed/NCBI
49	Hatcher CJ, Kim MS, Mah CS, Goldstein MM, Wong B, Mikawa T and Basson CT: TBX5 transcription factor regulates cell proliferation during cardiogenesis. Dev Biol. 230:177–188. 2001. View Article : Google Scholar : PubMed/NCBI
50	Hatcher CJ, Diman NY, Kim MS, Pennisi D, Song Y, Goldstein MM, Mikawa T and Basson CT: A role for Tbx5 in proepicardial cell migration during cardiogenesis. Physiol Genomics. 18:129–140. 2004. View Article : Google Scholar : PubMed/NCBI
51	Liberatore CM, Searcy-Schrick RD and Yutzey KE: Ventricular expression of tbx5 inhibits normal heart chamber development. Dev Biol. 223:169–180. 2000. View Article : Google Scholar : PubMed/NCBI
52	Al-Qattan MM and Abou Al-Shaar H: Molecular basis of the clinical features of Holt-Oram syndrome resulting from missense and extended protein mutations of the TBX5 gene as well as TBX5 intragenic duplications. Gene. 560:129–136. 2015. View Article : Google Scholar : PubMed/NCBI
53	Mori AD, Zhu Y, Vahora I, Nieman B, Koshiba-Takeuchi K, Davidson L, Pizard A, Seidman JG, Seidman CE, Chen XJ, et al: Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol. 297:566–586. 2006. View Article : Google Scholar : PubMed/NCBI